Company page

Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc. (IMDX) is a public company operating in the American market, with a market capitalization of approximately $175.66 million. The company focuses on developing innovative diagnostic solutions. Its commitment to advancing molecular diagnostics positions it as a key player in the healthcare industry.

profileIMDX:NASDAQAI content: aiUpdated June 24, 2026/company/insight-molecular-diagnostics-inc/c-1j7ch2iq
Insight Molecular Diagnostics Inc. logo
Ticker
IMDX:NASDAQ
Asset type
Stock
Market cap
$175.7M
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD